Webinar Recording: Current Perspectives and Future Trends in Diversion Detection Webinar

Jenny HarlettBlog

Recently we hosted an online symposium around the topic of diversion detection. We were honored to have four fantastic hosts for each one-hour session: “A Comprehensive Drug Diversion Program: Top 10 Critical Components Every Institution Should Have” by Dr. Christopher Fortier, Pharm.D., FASHP, chief pharmacy officer, Boston, MA “Nursing Perspective on Diversion and Role in a Controlled Substance Diversion Program … Read More

Kit Check Presents Groundbreaking Drug Diversion Symposium Featuring Top Industry Leaders

Jenny HarlettPress Release

Continuing education webinar addresses critical components, perspectives and best practices for hospitals, pharmacists and medical providers relating to controlled substances management and drug diversion WASHINGTON (January 14, 2020) – Kit CheckTM, the leader in automated and intelligent medication management solutions, today announced they will be hosting a first-of-its-kind continuing education online symposium, “Current Perspectives and Future Trends in Diversion Detection,” on … Read More

Bluesight for Controlled Substances featured in Quartz article about the role of tech in combating the opioid crisis

Jenny HarlettBlog, News

The nation is in the grip of a tragic opioid crisis, and drugs that are meant for hospital patients are finding their way into other hands. Controlled substance diversion in hospitals is one culprit that is receiving increasing scrutiny. Quartz recently took a look at ways that hospitals can combat diversion among providers, including the role that technology can play. … Read More

Kit Check’s Bluesight for Controlled Substances™ Recognized by KLAS as Leading Emerging Solution for Drug Diversion Monitoring

Jenny HarlettPress Release

Bluesight for Controlled Substances heralded in industry report, earns rating of 93.2 out of 100 WASHINGTON (August 20, 2019) — Kit CheckTM, the leader in automated medication management solutions for hospitals, today announced that its Bluesight for Controlled Substances (Bluesight) diversion prevention and controlled substance management solution has been recognized by leading analyst firm KLAS Research in its next-generation solution … Read More

Webinar: The Diversion Gap and What to Do About It

Jenny HarlettBlog

Kit Check’s Clinical Solutions Specialist AJ Rivosecchi, Pharm.D., recently held a webinar to discuss what we call the diversion gap—the space between controlled substance dispense activity and documentation where inventory can go missing. Hosted by IHFDA, the webinar covers key findings from our 2018 Hospital Pharmacy Operations Report, especially as they relate to the opioid crisis. AJ discusses the need … Read More

Nurses Unite: Impacting Change Around the Opioid Epidemic

Jenny HarlettBlog

This week we come together to celebrate the bravery, compassion, and determination of nurses. There are currently more than four million nurses practicing in the United States, and they are some of the most trusted professionals across any industry. Amid today’s opioid epidemic, which has claimed the lives of over 70,000 Americans, the American Nurses Association (ANA) recognizes the critical … Read More

The Data Science Behind Drug Diversion Detection with Bluesight for Controlled Substances

Jenny HarlettBlog

Data science has emerged as an ally for hospital directors of pharmacy in the continuous effort to close the “diversion gap”—the space where tracking and controls are incomplete and diverters conceal their activity. Simple math such as standard deviation and averages have proven inadequate in identifying controlled substance diverters who have become adept at covering their tracks. However, new machine … Read More

Venture Beat: Kit Check Launches AI to Catch Hospital Staff Stealing Drugs

Ava MutchlerBlog

Yesterday, Kit Check announced the launch of a new feature for Bluesight for Controlled Substances, the Individual Risk Identification Score (IRIS). Venture Beat covered the announcement as IRIS uses artificial intelligence to predict which employees pose the highest risk for controlled substance theft. Kit Check CEO Kevin MacDonald commented in the article, “The technology calculates how unusual one’s behavior is … Read More

Identifying Diversion by Location — A Practical Application of Machine Learning

Doug ZurawskiBlog

In the day-to-day battle against drug diversion, most solutions look at the data to find statistical outliers. Often the focus is on clinicians who may be logging more transactions than their peers, or on medications that are administered in unusual amounts or that go missing. We can call this the “Who” and the “What.” But we really have to look … Read More

Children’s Hospital of the King’s Daughters Closes Gap in Medication Diversion Controls with Bluesight for Controlled Substances

Hannah ByamBlog

Children’s Hospital of the King’s Daughters (CHKD) in Virginia is not unlike most hospitals in the United States. Preventing medication diversion was a clear priority, but identifying incidents was like finding a needle in a haystack.   Moving from Manual to ADCs Created a Data Gap CHKD had a manual, paper-based controlled substance auditing process and a full-time pharmacist dedicated … Read More

Airplane Engines, Hospital Pharmacies, and Controlled Substance Diversion Prevention

Kevin MacDonaldBlog

Health Connect Partners Fall 17 (#hcpchicago) just wrapped up in Chicago and, wow, was it a great show. While interacting with all of the pharmacy thought leaders in attendance, the topic that kept coming up was the issue of controlled substance compliance. The stage could not have been more ideally set for the unveiling of our latest product, Bluesight for Controlled Substances.

Launching Our Latest Product at HCP Fall 17

Kevin MacDonaldBlog

HCP Fall 17 is next week in Chicago. While I always enjoy HCP, this year’s event will be particularly meaningful for me. Not only is the event taking place in my hometown, Kit Check is launching an exciting new product to help hospitals get a better handle on controlled substance monitoring from dock to doc.